Cargando…
GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets
G protein-coupled receptors (GPCRs), the largest family of targets for approved drugs, are rarely targeted for cancer treatment, except for certain endocrine and hormone-responsive tumors. Limited knowledge regarding GPCR expression in cancer cells likely has contributed to this lack of use of GPCR-...
Autores principales: | Insel, Paul A., Sriram, Krishna, Wiley, Shu Z., Wilderman, Andrea, Katakia, Trishna, McCann, Thalia, Yokouchi, Hiroshi, Zhang, Lingzhi, Corriden, Ross, Liu, Dongling, Feigin, Michael E., French, Randall P., Lowy, Andrew M., Murray, Fiona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972277/ https://www.ncbi.nlm.nih.gov/pubmed/29872392 http://dx.doi.org/10.3389/fphar.2018.00431 |
Ejemplares similares
-
Detection and Quantification of GPCR mRNA: An Assessment
and Implications of Data from High-Content Methods
por: Sriram, Krishna, et al.
Publicado: (2019) -
GPCRomics of Homeostatic and Disease-Associated Human Microglia
por: Hsiao, Cheng-Chih, et al.
Publicado: (2021) -
GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors
por: Sriram, Krishna, et al.
Publicado: (2019) -
Quantitative Proteomics
Analysis of the cAMP/Protein
Kinase A Signaling Pathway
por: Guo, Yurong, et al.
Publicado: (2012) -
GPR68: An Emerging Drug Target in Cancer
por: Wiley, Shu Z., et al.
Publicado: (2019)